The winter of 2022 produced one of the most chaotic free-agent sagas in Major League Baseball history, centered entirely on star shortstop Carlos Correa. Within a matter of weeks, Correa agreed to massive contracts with three different franchises—the San Francisco Giants, the New York Mets, and the Minnesota Twins—with the midpoint of that wild ride featuring a shocking 12-year, $315 million agreement with Mets owner Steve Cohen. Medical concerns completely derailed what was supposed to be a straightforward coronation of a generational talent securing his financial future.
Understanding how a deal of this magnitude fractured, restructured, and ultimately redirected requires looking closely at the medical red flags, the fierce negotiations led by agent Scott Boras, and the unprecedented drama that unfolded behind closed doors. This breakdown examines the timeline, the physical examinations that stopped two monster contracts in their tracks, and how the fallout reshaped modern MLB free agency.
The Genesis: Setting the Stage for a Record Contract
Before the December 2022 winter meetings, Correa had already proven his worth as an elite defender and clutch postseason hitter. After opting out of his short-term deal with the Minnesota Twins, he entered the open market as one of the most coveted shortstops of his generation, alongside Trea Turner, Xander Bogaerts, and Dansby Swanson.
The San Francisco Giants moved quickly, agreeing to a 13-year, $350 million pact with Correa. Fans prepared for a massive introductory press conference at Oracle Park. Hours before the event, the Giants abruptly canceled it. Concerns regarding an old right fibula injury from his minor league days flagged during his physical exam caused the front office to balk at the multi-decade commitment.
The Midnight Pivot: The Mets Secure a 315 Million Deal
Scarcely had the ink dried on the collapsed San Francisco agreement when Scott Boras pivoted. Operating in deep-pocketed fashion under owner Steve Cohen, the New York Mets swooped in overnight. They struck a tentative agreement on a 12-year, $315 million contract, slotting Correa alongside Francisco Lindor to form a star-studded left side of the infield.
Cohen famously told the New York Post that the team just needed "one thing more" to push them over the top. Yet, history repeated itself in Queens. During the rigorous medical review, Mets doctors grew similarly alarmed by the historical stability of Correa's surgically repaired lower right leg. Weeks of tense negotiations over language to protect the franchise against long-term injury risk stalled the formal announcement.
Read more about historical player movement and team payrolls via MLB Official Site.
The Medical Impasse and the Return to Minnesota
The core issue across both failed mega-deals wasn't Correa's immediate ability to play baseball, but rather how his surgically repaired right fibula and ankle hardware would hold up in years 8, 10, or 12 of a long-term commitment. Teams were hesitant to lock in hundreds of millions of dollars without structural guarantees, while Boras and Correa pushed back against heavily team-favorable vesting options.
When talks with the Mets reached an unresolvable standstill, the Minnesota Twins re-entered the picture with remarkable speed. Having maintained open lines of communication throughout the entire ordeal, the Twins negotiated a revised 6-year, $200 million structure that included protective vesting thresholds based on plate appearances and physical health.
Key Factors That Derailed the Multiyear Mega-Deals
- Strict Medical Protocols: Modern front offices rely heavily on advanced imaging and third-party orthopedic specialists, making historical lower-extremity injuries deal-breakers for length over a decade.
- Guaranteed vs. Contingent Money: Both the Giants and Mets wanted safeguard language that drastically reduced guaranteed salary if chronic ankle or leg issues flared up, terms that Correa's representation initially resisted.
- Market Leverage Shifts: Once two consecutive physical examinations flagged the same joint, Correa lost the leverage of a bidding war, allowing Minnesota to structure a shorter, safer high-AAV framework.
Review official transaction logs and historical player statistics on Baseball Reference.
Frequently Asked Questions
Why did the San Francisco Giants back out of the original agreement?
The Giants grew alarmed by findings in Correa's physical examination regarding an old right lower-leg injury from 2014, leading them to postpone the introductory press conference and ultimately walk away from the 13-year term.
How did the New York Mets get involved so quickly?
Within hours of the Giants' deal collapsing, agent Scott Boras engaged with Mets owner Steve Cohen, who quickly authorized a 12-year, $315 million framework before medical reviews similarly complicated the arrangement.
What were the final terms of the contract Correa signed?
Correa ultimately returned to the Minnesota Twins on a six-year, $200 million contract containing heavy vesting options that protected the team while still paying him elite annual compensation.
Did the physical concerns impact his subsequent playing career?
While Correa dealt with intermittent lower-body injuries—such as plantar fasciitis in subsequent seasons—he continued to demonstrate elite defensive play and leadership when on the field.
